A new formulation of Gilead's HIV prevention drug, lenacapavir, has shown promise in providing yearlong protection with just one injection. The study, published in The Lancet, evaluated the ...

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.

US funding to fight HIV/AIDS has saved 26 million lives since 2003, with the greatest benefits felt in sub-Saharan Africa ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...

Source: Bringing HIV services to hard-to-reach people in Victoria Falls | UNAIDS When Desire speaks about his role as a peer ...

HIV-positive mothers with undetectable viral load can now safely breastfeed their infants, according to recently updated ...

USAID has been a major contributor to health- and population-linked projects in India over the last two decades. In recent ...

Founded 5 years ago, the Institute of HIV Research and Innovation works with communities to answer the research questions that matter most to them. Sima Barmania reports from Bangkok.

More than half of the people living with HIV in Philadelphia are 50 and older, and they face greater risk of frailty and impairment.

The withdrawal of Pepfar funding has left organisations grappling with devastating consequences, as two key players share ...